Sisira Yadala
Associate Professor
Also affiliated: University of Arkansas Medical Center (2022–2025); Baptist Health Foundation (2020); University of Applied Management Studies (2020); Temple University (2013)
Faculty Researcher
Neurology, College of Medicine
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Sisira Yadala's research focuses on neurological disorders, with a particular emphasis on epilepsy and its management. Her work includes investigating treatments for refractory epilepsy, such as the use of devices like Vagal Nerve Stimulators (VNS), Responsive Neurostimulation (RNS), and Deep Brain Stimulation (DBS). She also studies epilepsy in women and the efficacy of various medications, including Everolimus for seizures in Tuberous Sclerosis. Dr. Yadala's clinical interests extend to pre-surgical evaluations for epilepsy surgery and the interpretation of EEG monitoring, including invasive EEG monitoring.
Her recent publications reflect this focus, with contributions on the management of epilepsy through vagus nerve stimulation and analyses of treatment failures in anterior temporal lobectomies. Beyond epilepsy, her research has touched upon broader medical topics, including studies on thrombotic thrombocytopenic purpura (TTP) following COVID-19 vaccination, predictors of no-show appointments in neurology clinics, and the impact of the COVID-19 pandemic on stroke care utilization. She has also contributed to the understanding of neuroanatomy, specifically the corticobulbar tract.
Dr. Yadala's scholarship is supported by a network of collaborators at institutions including the University of Arkansas at Little Rock and within the University of Arkansas for Medical Sciences. Her work has resulted in 42 publications and garnered 419 citations, with an h-index of 7.
Research Overview
Dr. Sisira Yadala is an Assistant Professor of Neurology and Director of the Division of Epilepsy and Level 4 Comprehensive Epilepsy Center at the University of Arkansas for Medical Sciences (UAMS). Dr. Yadala is board certified by the Board of Psychiatry and Neurology in both Neurology and Epilepsy. Dr. Yadala graduated from Osmania Medical College, Hyderabad, India in 2007. She then completed a Preliminary Internal Medicine Residency at West Lake Hospital, Resurrection Health Systems, Melrose Park, Illinois in 2010 prior to joining the Temple University Hospital in Philadelphia, Pennsylvania where she completed her Neurology Residency in 2013, followed by completion of a Epilepsy/Clinical Neurophysiology Fellowship at New York University, New York, New York in 2014. Dr.Yadala’s expertise and clinical interests include management of refractory epilepsy (difficult to control epilepsy) , Video EEG monitoring, Invasive EEG monitoring, Pre-surgical evaluation for epilepsy surgery, Neuro-modulation with devices such as VNS (Vagal Nerve Stimulator), RNS (Responsive Neurostimulation) and DBS (Deep Brain Stimulation) and Epilepsy in women. Dr.Yadala treats patients at the Freeway Epilepsy and Neurology clinic.
Metrics
- h-index: 7
- Publications: 42
- Citations: 422
Selected Publications
-
Real-time EEG-guided Thalamic Deep Brain Stimulation Achieves Sustained Seizure Freedom in Catastrophic Epilepsy (P1-10.003) (2026)
-
Learning From Our Failures: When Anterior Temporal Lobectomies Fail (2026)
-
Acute Disruption of Cortical Epileptiform Discharges With Thalamic Stimulation (2025)
-
Heading: When change creates chaos - A dilemma with brand versus generic antiseizure medications,, (2025)
-
Vagus nerve stimulation for the management of epilepsy (2024)
-
Residency Attrition and Associated Characteristics, a 10-Year Cross Specialty Comparative Study (2022)
-
Approach to patients with autoimmune encephalitis with no identifiable antibodies (P2-1.001) (2022)
-
Everolimus for Treatment of Refractory Seizures in Tuberous Sclerosis (P3-8.002) (2022)
-
A case report of Granulomatous angiitis associated with Cogan syndrome. (P12-1.002) (2022)
-
Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: A systematic review of reported cases (2022)
-
Predictors of No-Show in Neurology Clinics (2022)
-
Continued Underutilization of stroke care during the COVID-19 pandemic (2021)
-
A 44-Year-Old Woman With a 10-Year History of Dyspnea and Pulmonary Nodules (2021)
-
Neuroanatomy, Corticobulbar Tract (2021)
-
EEG Benign Variants (2021)StatPearls OpenAlex
Grants & Funding
As listed on this researcher's institutional profile.
- A double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of intravenous ganaxolone in status epilepticus (IRB 262680) Marinus Pharmaceuticals Principal Investigator
Collaboration Network
Top Collaborators
- Predictors of No-Show in Neurology Clinics
- Continued Underutilization of stroke care during the COVID-19 pandemic
- EEG Benign Variants
- Predictors of No-Show in Neurology Clinics
- Continued Underutilization of stroke care during the COVID-19 pandemic
- EEG Benign Variants
- Everolimus for Treatment of Refractory Seizures in Tuberous Sclerosis (P3-8.002)
- A case report of Granulomatous angiitis associated with Cogan syndrome. (P12-1.002)
- Approach to patients with autoimmune encephalitis with no identifiable antibodies (P2-1.001)
- Everolimus for Treatment of Refractory Seizures in Tuberous Sclerosis (P3-8.002)
- A case report of Granulomatous angiitis associated with Cogan syndrome. (P12-1.002)
- Acute Disruption of Cortical Epileptiform Discharges With Thalamic Stimulation
- Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: A systematic review of reported cases
- A 44-Year-Old Woman With a 10-Year History of Dyspnea and Pulmonary Nodules
- Continued Underutilization of stroke care during the COVID-19 pandemic
- Approach to patients with autoimmune encephalitis with no identifiable antibodies (P2-1.001)
- Predictors of No-Show in Neurology Clinics
- Continued Underutilization of stroke care during the COVID-19 pandemic
- Everolimus for Treatment of Refractory Seizures in Tuberous Sclerosis (P3-8.002)
- A case report of Granulomatous angiitis associated with Cogan syndrome. (P12-1.002)
- Everolimus for Treatment of Refractory Seizures in Tuberous Sclerosis (P3-8.002)
- Approach to patients with autoimmune encephalitis with no identifiable antibodies (P2-1.001)
- Neuroanatomy, Corticobulbar Tract
- A 44-Year-Old Woman With a 10-Year History of Dyspnea and Pulmonary Nodules
- Continued Underutilization of stroke care during the COVID-19 pandemic
- Continued Underutilization of stroke care during the COVID-19 pandemic
- Continued Underutilization of stroke care during the COVID-19 pandemic
- Continued Underutilization of stroke care during the COVID-19 pandemic
Similar Researchers
Based on overlapping research topics